A Multiplex Snapback Primer System for the Enrichment and Detection of JAK2 V617F and MPL W515L/K Mutations in Philadelphia-Negative Myeloproliferative Neoplasms

被引:5
作者
Wu, Zhiyuan [1 ,2 ]
Zhang, Yunqing [3 ]
Zhang, Xinju [1 ]
Xu, Xiao [1 ]
Kang, Zhihua [4 ]
Li, Shibao [4 ]
Zhang, Chen [2 ]
Su, Bing [5 ]
Guan, Ming [1 ,2 ,4 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Cent Lab, Shanghai 200433, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Huashan Hosp North, Dept Lab Med, Shanghai 200433, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China
[5] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA
关键词
WORLD-HEALTH-ORGANIZATION; TYROSINE KINASE JAK2; EXON; 10; ESSENTIAL THROMBOCYTHEMIA; SENSITIVE DETECTION; MELTING ANALYSIS; MODIFIED PROBES; TIME; POLYMERASE; DNA;
D O I
10.1155/2014/458457
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A multiplex snapback primer system was developed for the simultaneous detection of JAK2 V617F and MPL W515L/K mutations in Philadelphia chromosome-(Ph-) negative myeloproliferative neoplasms (MPNs). The multiplex system comprises two snapback versus limiting primer sets for JAK2 and MPL mutation enrichment and detection, respectively. Linear-After exponential (LATE) PCR strategy was employed for the primer design to maximize the amplification efficiency of the system. Low ionic strength buffer and rapid PCR protocol allowed for selective amplification of the mutant alleles. Amplification products were analyzed by melting curve analysis for mutation identification. The multiplex system archived 0.1% mutation load sensitivity and <5% coefficient of variation inter-/intra-assay reproducibility. 120 clinical samples were tested by the multiplex snapback primer assay, and verified with amplification refractory system (ARMS), quantitative PCR (qPCR) and Sanger sequencing method. The multiplex system, with a favored versatility, provided the molecular diagnosis of Ph-negative MPNs with a suitable implement and simplified the genetic test process.
引用
收藏
页数:11
相关论文
共 40 条
  • [11] Snapback Primer Genotyping of the Gilbert Syndrome UGT1A1 (TA)n Promoter Polymorphism by High-Resolution Melting
    Farrar, Jared S.
    Palais, Robert A.
    Wittwer, Carl T.
    [J]. CLINICAL CHEMISTRY, 2011, 57 (09) : 1303 - 1310
  • [12] JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
    Harrison, Claire
    Kiladjian, Jean-Jacques
    Al-Ali, Haifa Kathrin
    Gisslinger, Heinz
    Waltzman, Roger
    Stalbovskaya, Viktoriya
    McQuitty, Mari
    Hunter, Deborah S.
    Levy, Richard
    Knoops, Laurent
    Cervantes, Francisco
    Vannucchi, Alessandro M.
    Barbui, Tiziano
    Barosi, Giovanni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) : 787 - 798
  • [13] SITE-DIRECTED MUTAGENESIS BY OVERLAP EXTENSION USING THE POLYMERASE CHAIN-REACTION
    HO, SN
    HUNT, HD
    HORTON, RM
    PULLEN, JK
    PEASE, LR
    [J]. GENE, 1989, 77 (01) : 51 - 59
  • [14] EXTENSION OF BASE MISPAIRS BY TAQ DNA-POLYMERASE - IMPLICATIONS FOR SINGLE NUCLEOTIDE DISCRIMINATION IN PCR
    HUANG, MM
    ARNHEIM, N
    GOODMAN, MF
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (17) : 4567 - 4573
  • [15] Novel multiplex bead-based assay with LNA-modified probes for detection of MPL exon 10 mutations
    Ivanova, Milena I.
    Shivarov, Velizar S.
    Hadjiev, Evgueniy A.
    Naumova, Elissaveta J.
    [J]. LEUKEMIA RESEARCH, 2011, 35 (08) : 1120 - 1123
  • [16] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
    Jones, AV
    Kreil, S
    Zoi, K
    Waghorn, K
    Curtis, C
    Zhang, LY
    Score, J
    Seear, R
    Chase, AJ
    Grand, FH
    White, H
    Zoi, C
    Loukopoulos, D
    Terpos, E
    Vervessou, EC
    Schultheis, B
    Emig, M
    Ernst, T
    Lengfelder, E
    Hehlmann, R
    Hochhaus, A
    Oscier, D
    Silver, RT
    Reiter, A
    Cross, NCP
    [J]. BLOOD, 2005, 106 (06) : 2162 - 2168
  • [17] A gain-of-function mutation of JAK2 in myeloproliferative disorders
    Kralovics, R
    Passamonti, F
    Buser, AS
    Teo, S
    Tiedt, R
    Passweg, JR
    Tichelli, A
    Cazzola, M
    Skoda, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1779 - 1790
  • [18] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
    Levine, RL
    Wadleigh, M
    Cools, J
    Ebert, BL
    Wernig, G
    Huntly, BJP
    Boggon, TJ
    Wlodarska, L
    Clark, JJ
    Moore, S
    Adelsperger, J
    Koo, S
    Lee, JC
    Gabriel, S
    Mercher, T
    D'Andrea, A
    Fröhling, S
    Döhner, K
    Marynen, P
    Vandenberghe, P
    Mesa, RA
    Tefferi, A
    Griffin, JD
    Eck, MJ
    Sellers, WR
    Meyerson, M
    Golub, TR
    Lee, SJ
    Gilliland, DG
    [J]. CANCER CELL, 2005, 7 (04) : 387 - 397
  • [19] Multiple mutations and cancer
    Loeb, LA
    Loeb, KR
    Anderson, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) : 776 - 781
  • [20] Germline JAK2 Mutation in a Family with Hereditary Thrombocytosis
    Mead, Adam J.
    Rugless, Michelle J.
    Jacobsen, Sten Eirik W.
    Schuh, Anna
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) : 967 - 969